Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Structure-Based Design of a Potent and Selective YTHDC1 Ligand.
Zálešák F, Nai F, Herok M, Bochenkova E, Bedi RK, Li Y, Errani F, Caflisch A. Zálešák F, et al. Among authors: herok m. J Med Chem. 2024 Jun 13;67(11):9516-9535. doi: 10.1021/acs.jmedchem.4c00599. Epub 2024 May 24. J Med Chem. 2024. PMID: 38787793 Free PMC article.
Small-Molecule Inhibitors of the m7G-RNA Writer METTL1.
Nai F, Flores Espinoza MP, Invernizzi A, Vargas-Rosales PA, Bobileva O, Herok M, Caflisch A. Nai F, et al. Among authors: herok m. ACS Bio Med Chem Au. 2023 Dec 12;4(2):100-110. doi: 10.1021/acsbiomedchemau.3c00030. eCollection 2024 Apr 17. ACS Bio Med Chem Au. 2023. PMID: 38645929 Free PMC article.
Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation.
Tracz-Gaszewska Z, Klimczak M, Biecek P, Herok M, Kosinski M, Olszewski MB, Czerwińska P, Wiech M, Wiznerowicz M, Zylicz A, Zylicz M, Wawrzynow B. Tracz-Gaszewska Z, et al. Among authors: herok m. Oncotarget. 2017 Jun 30;8(47):82123-82143. doi: 10.18632/oncotarget.18899. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137250 Free PMC article.